AU2001265876A1 - Novel use of pulmonary surfactant for the prophylaxis or early treatment of acute pulmonary diseases - Google Patents

Novel use of pulmonary surfactant for the prophylaxis or early treatment of acute pulmonary diseases

Info

Publication number
AU2001265876A1
AU2001265876A1 AU2001265876A AU6587601A AU2001265876A1 AU 2001265876 A1 AU2001265876 A1 AU 2001265876A1 AU 2001265876 A AU2001265876 A AU 2001265876A AU 6587601 A AU6587601 A AU 6587601A AU 2001265876 A1 AU2001265876 A1 AU 2001265876A1
Authority
AU
Australia
Prior art keywords
prophylaxis
pulmonary
early treatment
novel use
acute
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2001265876A
Inventor
Dietrich Hafner
Christoph Karl
Andreas Keller
Frank Rathgeb
Peter Schaffer
Wilhelm Wurst
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Takeda GmbH
Original Assignee
Byk Gulden Lomberg Chemische Fabrik GmbH
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Byk Gulden Lomberg Chemische Fabrik GmbH filed Critical Byk Gulden Lomberg Chemische Fabrik GmbH
Publication of AU2001265876A1 publication Critical patent/AU2001265876A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/1703—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • A61K38/1709—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/14—Drugs for disorders of the endocrine system of the thyroid hormones, e.g. T3, T4

Abstract

The invention describes the novel use of pulmonary surfactant preparations for the prophylaxis or early treatment of acute pulmonary diseases.
AU2001265876A 2000-04-12 2001-04-12 Novel use of pulmonary surfactant for the prophylaxis or early treatment of acute pulmonary diseases Abandoned AU2001265876A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP00107858 2000-04-12
EP00107858 2000-04-12
PCT/EP2001/004223 WO2001076619A1 (en) 2000-04-12 2001-04-12 Novel use of pulmonary surfactant for the prophylaxis or early treatment of acute pulmonary diseases

Publications (1)

Publication Number Publication Date
AU2001265876A1 true AU2001265876A1 (en) 2001-10-23

Family

ID=8168443

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2001265876A Abandoned AU2001265876A1 (en) 2000-04-12 2001-04-12 Novel use of pulmonary surfactant for the prophylaxis or early treatment of acute pulmonary diseases

Country Status (12)

Country Link
US (1) US20030158087A1 (en)
EP (1) EP1276495B1 (en)
JP (1) JP2003530356A (en)
AT (1) ATE323505T1 (en)
AU (1) AU2001265876A1 (en)
CA (1) CA2405811C (en)
DE (1) DE60118898T2 (en)
DK (1) DK1276495T3 (en)
ES (1) ES2262656T3 (en)
PT (1) PT1276495E (en)
SI (1) SI1276495T1 (en)
WO (1) WO2001076619A1 (en)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20040254112A1 (en) * 2000-04-12 2004-12-16 Dietrich Hafner Use of pulmonary surfactant for the early treatment of acute pulmonary diseases
AU2002357168A1 (en) 2001-12-12 2003-07-09 Penn State Research Foundation Surfactant prevention of lung complications from cancer chemotherapy
ITMI20021058A1 (en) * 2002-05-17 2003-11-17 Chiesi Farma Spa MIXTURES OF SYNTHETIC LIPIDS OPTIMIZED FOR THE PREPARATION OF A RECONSTITUTED SURFACTANT
US7238664B2 (en) * 2003-06-16 2007-07-03 Altana Pharma Ag Composition comprising a pulmonary surfactant and a PDE5 inhibitor for the treatment of lung diseases
ES2339954T3 (en) 2004-08-06 2010-05-27 Nycomed Gmbh COMPOSITION THAT INCLUDES A PULMONARY TENSIOACTIVE AGENT AND A PEPTIDE DERIVED FROM TNF.
RU2577698C2 (en) * 2009-03-26 2016-03-20 Пулмэтрикс, Инк. Dry powder formulations and methods of treating pulmonary diseases
EP2407150A1 (en) * 2010-07-16 2012-01-18 Justus-Liebig-Universität Gießen Polymer nano and micro particles for the maintenance of the low surface tension in the lung and for the protection of the pulmonary surfactant

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6013619A (en) * 1988-01-06 2000-01-11 The Scripps Research Institute Pulmonary surfactants and therapeutic uses, including pulmonary lavage
GB9021080D0 (en) * 1990-09-26 1990-11-07 Univ Western Ontario Lipid extract surfactant and method of producing same
DE4418936A1 (en) * 1994-05-31 1996-02-08 Byk Gulden Lomberg Chem Fab Polypeptide
DE4434629C1 (en) * 1994-09-28 1996-06-27 Byk Gulden Lomberg Chem Fab IRDS and ARDS treatment compositions
US6129934A (en) * 1995-06-07 2000-10-10 Ony, Inc. Modification of animal lung surfactant for treating respiratory disease due to lung surfactant deficiency or dysfunction
JP3561764B2 (en) * 1997-05-21 2004-09-02 雅也 田中 Respiratory disease drug
DE19827907C2 (en) * 1998-06-23 2003-05-15 Altana Pharma Ag New pharmaceutical compositions for the treatment of IRDS and ARDS
AU1161300A (en) * 1998-11-10 2000-05-29 Byk Gulden Lomberg Chemische Fabrik Gmbh Treatment set containing lungsurfactant compositions
EP1173194B1 (en) * 1999-01-19 2004-06-16 ALTANA Pharma AG Recombinant sp-a for the treatment or prevention of pulmonary infection and inflammation
US20040254112A1 (en) * 2000-04-12 2004-12-16 Dietrich Hafner Use of pulmonary surfactant for the early treatment of acute pulmonary diseases

Also Published As

Publication number Publication date
ATE323505T1 (en) 2006-05-15
CA2405811C (en) 2011-09-27
DK1276495T3 (en) 2006-08-14
US20030158087A1 (en) 2003-08-21
CA2405811A1 (en) 2001-10-18
DE60118898D1 (en) 2006-05-24
EP1276495B1 (en) 2006-04-19
DE60118898T2 (en) 2006-11-16
ES2262656T3 (en) 2006-12-01
SI1276495T1 (en) 2006-10-31
PT1276495E (en) 2006-08-31
WO2001076619A1 (en) 2001-10-18
JP2003530356A (en) 2003-10-14
EP1276495A1 (en) 2003-01-22

Similar Documents

Publication Publication Date Title
AU5242000A (en) Nematicidal trifluorobutenes
ZA200306806B (en) Preparation for the prophylaxis of restenosis.
AU2001278003A1 (en) Bacteriophage having multiple host range
MXPA03002814A (en) Morpholin-acetamide derivatives for the treatment of inflammatory diseases.
AU2002341920A1 (en) Chemical compounds
DK1206474T3 (en) Sulfonylphenylpyrazole compounds useful as cox-2 inhibitors
AU2002310187A1 (en) Inhibitors of protein kinase for the treatment of disease
NO20034056D0 (en) Proliferative diseases
WO2002030353A3 (en) NF-λB INHIBITORS
AU2001235006A1 (en) Prophylactic and therapeutic monoclonal antibodies
AU2002210385A1 (en) Furazanyl-triazole derivates for the treatment of diseases
MXPA03003741A (en) Methods and compositions for the treatment of diseases of the eye.
WO2004091436A3 (en) Methods and compositions for treating ocular disease
AU2001265876A1 (en) Novel use of pulmonary surfactant for the prophylaxis or early treatment of acute pulmonary diseases
AU2002362505A1 (en) Compression sleeve for treatment of the extremities
WO2003051838A3 (en) Protein kinase inhibitors
AU2002251202A1 (en) Intimins for the prevention or treatment of infections: i
AU2002330245A1 (en) Isolated polypeptides and compositions from the venom of p. transvaalicus and methods of use
AU2003259159A1 (en) N-aryl-2-oxazolidinones and their derivatives
AU4453301A (en) Use of spirolaxin for the treatment of diseases associated with abnormal angiogenesis
WO2001039573A3 (en) Novel use of lung surfactant for treating legionnaire's disease
AU2002324469A1 (en) Substituted-heteroaryl-7-aza(2.2.1)bicycloheptanes for the treatment of disease
AU2002229479B2 (en) Preparation for the prophylaxis of restenosis
AU2002303821A1 (en) Aryl-8-azabicyclo(3.2.1)octanes for the treatment of depression
AU2002229479A1 (en) Preparation for the prophylaxis of restenosis